Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Neoplasms 18Recurrence 17Pancreatic Neoplasms 17Multiple Myeloma 15Prostatic Neoplasms 12Advanced Solid Tumors 12Advanced Solid Tumor 12Carcinoma, Hepatocellular 11Stomach Neoplasms 10Ovarian Neoplasms 10Leukemia, Myeloid, Acute 10Triple Negative Breast Neoplasms 8Small Cell Lung Carcinoma 7Neoplasm Metastasis 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Solid Tumor 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Endometrial Neoplasms 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Myeloid Malignancies × Clear all
NCT06917105 2025-04-08

Exploratory Clinical Study on the Safety and Efficacy of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Myeloid Malignancies

Tongji Hospital

Phase 1/2 Not yet recruiting
45 enrolled

Myeloid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡